Home » Topics » BioWorld Science

BioWorld Science
RSS

Sanofi begins phase I/II study of SAR-439483 in LCA caused by GUCY2D mutations

Oct. 16, 2019

Aura updates data from phase Ib/II study of AU-011 in primary choroidal melanoma

Oct. 16, 2019

Principia Biopharma reports preliminary data from phase I/II trial of PRN-1008 in ITP

Oct. 16, 2019

Novavax begins pivotal trial of NanoFlu in older adults

Oct. 16, 2019

[212Pb]Rituximab treatment to overcome hematological toxicity in non-Hodgkin's lymphoma

Oct. 16, 2019

Pfizer identifies muscarinic acetylcholine M4 receptor agonists

Oct. 16, 2019

New eukaryotic translation initiation factor 2B activators patented by Denali Therapeutics

Oct. 16, 2019

Surprise discovery may improve malaria vaccine strategy

Oct. 16, 2019

Medipol University discovers hexokinase-2 inhibitors

Oct. 16, 2019

Kappa-opioid receptor antagonists presented by the University of Kansas, University of Florida

Oct. 16, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...